Stay updated on Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a small administrative update to the study record. There are no visible changes to the study details or layout reflected by this update.SummaryDifference0.0%

- Check17 days agoChange DetectedThe Taiwan location entry was updated to reflect Taoyuan as the city instead of Taoyuan District, aligning the site listing with standard naming in the study's locations.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page footer’s software/content revision label was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check38 days agoChange DetectedThe collaborator name has been updated to Ono Pharmaceutical Co., Ltd and the revision version changed from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check45 days agoChange DetectedPadua, Italy was replaced with Padova, Italy in the study locations list (local name Padova).SummaryDifference0.0%

- Check67 days agoChange DetectedPage version updated from v3.4.3 to v3.5.0. This appears to be a technical update that does not change trial details or results.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.